Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates

Current Opinion in Organ Transplantation

Volumn 16, Issue 2, 2011, Pages 222-230

  Ekser, Burcin ^a,b   Kumar, Goutham ^a   Veroux, Massimiliano ^b   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

1,3 galactosyltransferase gene knockout; complement regulatory proteins; organs; xenotransplantation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 1,3 GALACTOSYLTRANSFERASE; CD40 LIGAND MONOCLONAL ANTIBODY; COBROTOXIN; CORTICOSTEROID; HEPARIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; BLOOD CLOTTING DISORDER; CELL THERAPY; DNA MODIFICATION; GENE INACTIVATION; GENETIC ENGINEERING; GRAFT SURVIVAL; HEART TRANSPLANTATION; KIDNEY GRAFT; LOW DRUG DOSE; NONHUMAN; ORGAN TRANSPLANTATION; SPLENECTOMY; SWINE; XENOTRANSPLANTATION;

ANIMALS; BLOOD COAGULATION DISORDERS; GALACTOSYLTRANSFERASES; GENE KNOCKOUT TECHNIQUES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PRIMATES; SWINE; TIME FACTORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 79954576318     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283446c3c     Document Type: Article

References (58)

1. Phelps CJ, Koike C, Vaught TD, et al. Production of 1,3- galactosyltransferasedeficient pigs. Science 2003; 299:411-414.
2. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboon through the use of alpha 1,3- galactosyltransferase gene-knockout donors and the cotransplantation of thymic tissue. Nat Med 2005; 11:32-34. (Pubitemid 40215834)
3. Kuwaki K, Tseng YL, Dor FJMF, et al. Heart transplantation in baboons using a1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11:29-31. (Pubitemid 40215833)
4. Ekser B, Rigotti P, Gridelli B, Cooper DKC. Xenotransplantation of solid organs in the pig-to-primate model. Transplant Immunol 2009; 21:87-92.
5. Ekser B, Cooper DKC. Overcoming the barriers to xenotransplantation: prospects for the future. Expert Rev Clin Immunol 2010; 6:219-230.
6. Azimzadeh AM, Kelishadi SS, Ezzelarab M, et al. Early graft failure of GTKO pig organs in baboons is reduced by hCPRP expression. (Abstract IXA-O-2.2). Xenotransplantation 2009; 16:356.
7. Burdorf L, Stoddard T, Zhang T, et al. Does addition of CTLA4Ig to an anti- CD154-based regimen prevent antinon-Gal antibody production after GalTKO or GalTKO/hCRP pig organ xenografting? (Abstract IXA-O-5.6). Xenotransplantation 2009; 16:368.
8. Byrne GW, Ricci D, Miyagi N, et al. Comparison of GTKO and GTKO;hDAF donor organs in heterotopic cardiac xenotransplantation. (Abstract ATC-653). Am J Transplant 2009; 9 (suppl 2):380.
9. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in a1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009; 87:805-812.
10. Brenner P, Postrach J, Bauer A, et al. The worldwide first model of heterotopic thoracic xenogeneic heart transplantation compared with the heterotopic abdominal technique. (Abstract TTS-800). Transplantation 2010; 90 (suppl):326.
11. Mohiuddin MM, Corcoran PC, Singh AK, et al. Over six month survival of cardiac xenograft is achievable but heterotopic placement of the graft may limit consistent prolonged survival. (Abstract TTS-1383). Transplantation 2010; 90 (suppl):325.
12. Bauer A, Postrach J, Thormann M, et al. First experience with heterotopic thoracic pig-to-baboon cardiac xenotransplantation. Xenotransplantation 2010; 17:243-249.
13. McGregor CGA, Byrne GW, Vlasin M, et al. Early cardiac function and gene expression after orthotopic cardiac xenotransplantation. (Abstract IXA-O-2.4). Xenotransplantation 2009; 16:356.
14. Mohiuddin MM, Singh AK, Corcoran PC, et al. B cell depletion of anti-CD20 prolongs GALKO.hCD46 pig heterotopic cardiac xenograft survival in baboons. (Abstract IXA-O-2.5). Xenotransplantation 2009; 16:357.
15. Corcoran PC, Horvath KA, Singh AK, et al. Surgical and nonsurgical complications of a pig to baboon heterotopic heart xenotransplantation model. Transplant Proc 2010; 42:2149-2151.
16. Yeh P, Ezzelarab M, Bovin N, et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010; 17:197-206.
17. Novitzky D, Cooper DKC, Barnard CN. The surgical technique of heterotopic heart transplantation. Ann Thorac Surg 1983; 36:476-482. (Pubitemid 13015009)
18. McGregor C. Xenogeneic orthotopic heart transplantation: where are we now? Xenotransplantation 2010; 17:114.
19. Cozzi E, Simioni P, Nottle MB, et al. Preliminary study in a life supporting pig to primate xenotransplantation model using GAL KO pigs transgenic for human CD39, CD55, CD59 and fucosyltransferase (Abstract LB IXA O-4). Xenotransplantation 2009; 16:544.
20. Griesemer AD, Hirakata A, Shimizu A, et al. Results of Gal-knockout porcine thymokidney xenografts. Am J Transplant 2009; 9:2669-2678.
21. Le Bas-Bernardet S, Tillou X, Poirier N, et al. First xenotransplantations of GAL KO, CD55, CD59, CD39, HT transgenic pig kidneys in baboons. (Abstract LB IXA O-3). Xenotransplantation 2009; 16:543.
22. Salvaris E, Hawthorne WJ, Peirce S, et al. Improved survival of GalT KO/ hCD55-hCD59 pig renal xenografts in nonimmunosuppressed baboons. (Abstract IXA-O-2.9). Xenotransplantation 2009; 16:358.
23. Griesemer AD, Liang F, Hirataka A, et al. Occurrence of specific humoral nonresponsiveness to swine antigens following administration of GalT-KO bone marrow to baboons. Xenotransplantation 2010; 17:300-312.
24. Lin CC, Ezzelarab M, Shapiro R, et al. Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 2010; 10:1556-1568.
25. Nishimura H, Shimizu A, Griesemer A, et al. High levels of cytotoxic antinon Gal preformed natural antibody did not induce hyperacute rejection but did cause early graft loss in a GalT-KO pig-to-baboon thymokidney model. (Abstract TTS-2413). Transplantation 2010; 90 (suppl):311.
26. Harnden I, Kiernan K, Kearns-Jonker M. The antinonGal xenoantibody response to alpha1,3-galactosyltransferase gene knockout pig xenografts. Curr Opin Organ Transpl 2010; 15:207-211.
27. Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons after genetically modified pig liver transplants: clinical relevance. Am J Transplant 2010; 10:273-285.
28. Ekser B, Echeverri GJ, Cortese Hassett A, et al. Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation 2010; 90:483-493.
29. Ekser B, Gridelli B, Tector AJ, Cooper DKC. Pig liver transplantation as a bridge to allotransplantation: which patients might benefit? Transplantation 2009; 88:1041-1049.
30. Schmelzle M, Schulte Esch J 2nd, Robson SC. Coagulation, platelet activation and thrombosis in xenotransplantation. Curr Opin Organ Transplant 2010; 15:212-218.
31. Cowan PJ, Roussell JC, d'Apice AJF. The vascular and coagulation issues in xenotransplantation. Curr Opin Organ Transplant 2009; 14:161-167.
32. Cowan PJ, d'Apice AJF. Complement activation and coagulation in xenotransplantation. Immunol Cell Biol 2009; 87:203-208.
33. Cowan et al. Curr Opin Organ Transplant 2011.
34. Byrne GW, Davies WR, Oi K, et al. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival. Transplantation 2006; 82:1787-1791. (Pubitemid 46035668)
35. Kawai T, Sogawa H, Boskovic S, et al. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 2004; 4:1391-1398. (Pubitemid 39159053)
36. Kawai T, Andrews D, Colvin RB, et al. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000; 6:114. (Pubitemid 30082329)
37. Knosalla C, Gollackner B, Cooper DKC. Anti-CD154 monoclonal antibody and thromboembolism revisited. Transplantation 2002; 74:416-417.
38. Knosalla C, Yazawa K, Behdad A, et al. Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation. Am J Transplant 2009; 9:1006-1016.
39. Miyagawa S, Yamamoto A, Matsunami K, et al. Complement regulation in the GalT KO era. Xenotransplantation 2010; 17:11-25.
40. Muller YD, Golshayan D, Ehirchiou D, et al. T regulatory cells in xenotransplantation. Xenotransplantation 2009; 16:121-128.
41. O'Connell PJ, Yi S, Carrington EM, Lew AM. Role of regulatory T cells in xenotransplantation. Curr Opin Organ Transpl 2010; 15:224-229.
42. Sun L, Yi S, O'Connell PJ. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response. Xenotransplantation 2010; 17:121-130.
43. Dons EM, Raimondi G, Cooper DKC, Thomson AW. Nonhuman primate regulatory T cells: current biology and implications for transplantation. Transplantation 2010; 90:811-816.
44. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371:1579-1586. (Pubitemid 351626841)
45. Ezzelarab M, Ayares D, Cooper DKC. The potential of genetically-modified pig mesenchymal stromal cells in xenotransplantation. Xenotransplantation 2010; 17:3-5.
46. Phelps CJ, Ball SF, Vaught TD, et al. Production and characterization of transgenic pigs expressing CTLA4-Ig. Xenotransplantation 2009; 16:477-485.
47. Weiss EH, Lilienfeld BG, Mü ller S, et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human antipig natural killer cell cytotoxicity. Transplantation 2009; 87:35-43.
48. Choi KM, Jin DI, Hong SP, et al. Production of transgenic cloned miniature pigs with membrane-bound human Fas ligand (FasL) by somatic cell nuclear transfer. Nat Precedings 2010; in press (http://precedings.nature.com/ documents/4539/version/1/files/npre20104539-1.pdf).
49. Hara H, Crossley T, Witt W, et al. Dominant-negative CIITA transgenic pigs: effect on the human antipig T cell immune response and immune status. (Abstract ATC-503). Am J Transplant 2010; 10 (Suppl 4):137.
50. Oropeza M, Petersen B, Carnwath JW, et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 2009; 16:522-534.
51. Petersen B, Lucas-Harn A, Lemme E, et al. Generation and characterization of pigs transgenic for human hemeoxygenase-1 (hHO-1). Xenotransplantation 2010; 17:102-103.
52. Peterson B, Ramackers W, Tiede A, et al. Pigs transgenic for human thrombomodulin have elevated production of activated protein C. Xenotransplantation 2009; 16:486-495.
53. Dieckhoff B, Peterson B, Kues WA, et al. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 2008; 15:36-45. (Pubitemid 351360240)
54. Ramsoondar J, Vaught T, Ball S, et al. Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation 2009; 16:164-180.
55. Miwa Y, Yamamoto K, Onishi A, et al. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation. Xenotransplantation 2010; 17:26-37.
56. Plege A, Schwinzer R. Stimulatory and inhibitory receptor interactions in xenotransplantation. Curr Opin Organ Transpl 2010; 15:219-223.
57. van der Windt DJ, Smetanka C, Macedo C, et al. Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys. Am J Transplant 2010; 10:773-783.
58. Nagashima H, Matsunari H, Umeyama K. Recent advances in production of genetically modified pigs for xenotransplantation. Xenotransplantation 2010; 17:104-105.